Literature DB >> 15635008

Evidence for preferential genotyping of a minority human immunodeficiency virus population due to primer-template mismatching during PCR-based amplification.

Javier Martinez-Picado1, Kristina Morales-Lopetegi, Cristina Villena, Carolina Gutiérrez, Nuria Izquierdo, Silvia Marfil, Bonaventura Clotet, Lidia Ruiz.   

Abstract

Human immunodeficiency virus type 1 (HIV-1) genotyping assays have come to be widely used for monitoring antiretroviral drug resistance. We report a case in which primer-template mismatches during nested PCR-based amplification biased the composition of the original viral population in the sample, magnifying a distinct minority HIV-1 population. This observation might help to explain some unexpected HIV-1 genotypes.

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15635008      PMCID： PMC540107          DOI： 10.1128/JCM.43.1.436-438.2005

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  23 in total

1.  Drug-resistance genotyping in HIV-1 therapy: the VIRADAPT randomised controlled trial.

Authors:  J Durant; P Clevenbergh; P Halfon; P Delgiudice; S Porsin; P Simonet; N Montagne; C A Boucher; J M Schapiro; P Dellamonica
Journal:  Lancet       Date:  1999-06-26       Impact factor: 79.321

2.  Discrimination of primer 3'-nucleotide mismatch by taq DNA polymerase during polymerase chain reaction.

Authors:  S Ayyadevara; J J Thaden; R J Shmookler Reis
Journal:  Anal Biochem       Date:  2000-08-15       Impact factor: 3.365

3.  A patient with HIV-1 superinfection.

Authors:  Stephanie Jost; Marie-Charlotte Bernard; Laurent Kaiser; Sabine Yerly; Bernard Hirschel; Assia Samri; Brigitte Autran; Li-Ean Goh; Luc Perrin
Journal:  N Engl J Med       Date:  2002-09-05       Impact factor: 91.245

4.  Mechanisms of virologic failure in previously untreated HIV-infected patients from a trial of induction-maintenance therapy. Trilège (Agence Nationale de Recherches sur le SIDA 072) Study Team).

Authors:  D Descamps; P Flandre; V Calvez; G Peytavin; V Meiffredy; G Collin; C Delaugerre; S Robert-Delmas; B Bazin; J P Aboulker; G Pialoux; F Raffi; F Brun-Vézinet
Journal:  JAMA       Date:  2000-01-12       Impact factor: 56.272

5.  Clinical utility of HIV-1 genotyping and expert advice: the Havana trial.

Authors:  Cristina Tural; Lidia Ruiz; Christopher Holtzer; Jonathan Schapiro; Pompeyo Viciana; Juan González; Pere Domingo; Charles Boucher; C Rey-Joly; Bonaventura Clotet
Journal:  AIDS       Date:  2002-01-25       Impact factor: 4.177

6.  Worldwide evaluation of DNA sequencing approaches for identification of drug resistance mutations in the human immunodeficiency virus type 1 reverse transcriptase.

Authors:  R Schuurman; L Demeter; P Reichelderfer; J Tijnagel; T de Groot; C Boucher
Journal:  J Clin Microbiol       Date:  1999-07       Impact factor: 5.948

7.  A randomized study of antiretroviral management based on plasma genotypic antiretroviral resistance testing in patients failing therapy. CPCRA 046 Study Team for the Terry Beirn Community Programs for Clinical Research on AIDS.

Authors:  J D Baxter; D L Mayers; D N Wentworth; J D Neaton; M L Hoover; M A Winters; S B Mannheimer; M A Thompson; D I Abrams; B J Brizz; J P Ioannidis; T C Merigan
Journal:  AIDS       Date:  2000-06-16       Impact factor: 4.177

8.  Usefulness of monitoring HIV drug resistance and adherence in individuals failing highly active antiretroviral therapy: a randomized study (ARGENTA).

Authors:  Antonella Cingolani; Andrea Antinori; Maria Gabriella Rizzo; Rita Murri; Adriana Ammassari; Francesco Baldini; Simona Di Giambenedetto; Roberto Cauda; Andrea De Luca
Journal:  AIDS       Date:  2002-02-15       Impact factor: 4.177

9.  High degree of interlaboratory reproducibility of human immunodeficiency virus type 1 protease and reverse transcriptase sequencing of plasma samples from heavily treated patients.

Authors:  R W Shafer; K Hertogs; A R Zolopa; A Warford; S Bloor; B J Betts; T C Merigan; R Harrigan; B A Larder
Journal:  J Clin Microbiol       Date:  2001-04       Impact factor: 5.948

10.  Antiretroviral resistance during successful therapy of HIV type 1 infection.

Authors:  J Martinez-Picado; M P DePasquale; N Kartsonis; G J Hanna; J Wong; D Finzi; E Rosenberg; H F Gunthard; L Sutton; A Savara; C J Petropoulos; N Hellmann; B D Walker; D D Richman; R Siliciano; R T D'Aquila
Journal:  Proc Natl Acad Sci U S A       Date:  2000-09-26       Impact factor: 11.205
View more
  1 in total

1.  Both human immunodeficiency virus cellular DNA sequencing and plasma RNA sequencing are useful for detection of drug resistance mutations in blood samples from antiretroviral-drug-naive patients.

Authors:  Saverio G Parisi; Caterina Boldrin; Mario Cruciani; Giangiacomo Nicolini; Isabella Cerbaro; Vinicio Manfrin; Federico Dal Bello; Elisa Franchin; Marzia Franzetti; Maria C Rossi; Anna M Cattelan; Laura Romano; Maurizio Zazzi; Massimo Andreoni; Giorgio Palù
Journal:  J Clin Microbiol       Date:  2007-04-18       Impact factor: 5.948
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.